// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

The New Cardiac Bedside Assessment: Integrating Hand-Held Cardiac Ultrasound into the Evaluation of Cardiac Patients

Julie A. Gilmour - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Mitral valve regurgitation

Methadone hydrochloride

Overexpression of MicroRNA-126 Promotes Angiogenesis in a Vascular Endothelial Growth Factor Receptor 2 (VEGFR-2) and Tyrosine Kinase with Immunoglobulin-like and EGF-like Domains 2 (Tie2) Dependent Manner in Hindlimb Chronic Ischemia

Wei J Cao - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

L-Tyrosine

Angiopoietin Like-2 Contributes to Cerebral Artery Endothelial Dysfunction in Mice

Cecile Martel - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Vasodilation dysfunction

N-acetylcysteine

Calibration and Feedback of Speckle Strain Measurement Improves Segmental Strain Concordance

Kazuaki Negishi - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Inflammation and Ischemic Heart Failure: Monocyte-Mediated Cardiac Fibroblast Activation and Matrix Remodeling Through a Direct Cell-Cell Contact Mechanism

Brodie D Lipon - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

N/A

Efficient and Persistent Transgene Expression by Minicircle Plasmid versus Standard Plasmid Using Ultrasound Targeted Microbubble Destruction

Pratiek N Matkar - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Re-hospitalization Rates Following Stroke and Major Bleeding in Nonvalvular Atrial Fibrillation Patients

Michael Stokes - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Non-valvular atrial fibrillation

N/A

Novel Apolipoprotein E-derived ABCA1 Agonist Peptide (CS-6253) Promotes Reverse Cholesterol Transport in vitro and Induces de novo Formation of Apoa-I Containing pre?-1 HDL in Human Plasma

John K Bielicki - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

Choline bitartrate

Ablation of Aryl Hydrocarbon Nuclear Translocator (ARNT) in the Heart Leads to Diabetic Cardiomyopathy Phenotype Through PPAR? Activity

Hsiang Chun Chang - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetic cardiomyopathy

N/A

Pulmonary Hypertension is Associated with Apoptosis, the Downregulation of S100A1, the Upregulation of S100A6 and the Receptor for Advanced Glycation end-Products

Vassilios Salpeas - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

N/A

Children After Fontan have the Strength, Body Composition, and Daily Moderate-to-Vigorous Physical Activity Required for Successful Participation with Peers

Mary Corey - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Loss of Mitochondrial UCP3-Cytochrome c Oxidase Complexes Underlies Maladaptive Autophagy and Cardiac Failure in Anthracycline Cardiotoxicity

Victoria Margulets - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Mitochondrial Injury

Doxorubicin

Is Accurate Stroke Risk ssessment with CHADS2 Necessary in Managing Patients with Atrial Fibrillation? Insights from the Stroke Prevention and Rhythm Interventions in Atrial Fibrillation (SPRINT-AF) Registry

Narendra Singh - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Arrhythmia

N/A

Implementation of a Knowledge Translation and Education Tool to Improve Appropriate Use of Stress Echocardiography at a Large Academic Medical Center in a Public Funded Healthcare System

Chi-Ming Chow - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Restoration of Interleukin-10 Levels in Differentiated Mesenchymal Stem Cells Preserves their Immunoprivilege in Allogeneic Implantation and Restores Post-Infarction Cardiac Function

Jun Wu - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Interleukin-10

High Rates of antiplatelet Use in Atrial Fibrillation Patients Treated With Oral Anticoagulation: Insights from the Stroke Prevention and Rhythm Interventions in Atrial Fibrillation (SPRINT-AF) Registry

Narendra Singh - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Peripheral artery disease

Aspirin

Angiopoietin Like-2 Knockdown Worsens Pressure Overload-Induced Cardiac Dysfunction Despite Preserving Vascular Endothelial Integrity in Mice

Adeline Raignault - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Vasodilation dysfunction

Acetylcholine

Direct Renin Inhibition With Aliskiren Improves Ischemia-Induced Neovascularization

Sylvie Dussault - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

Nitric oxide

The Infusion of Mesenchymal Stromal Cells Post Myocardial Infarction Increases Myocardial S100A6, Attenuates Myocyte Hypertrophy, Reduces Myocyte Apoptosis and Improves Cardiac Function

Shehla Izhar - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

N/A

Nutritional Support With Medium Chain Fatty Acids During Extracorporeal Membrane Oxygenation in Infant Swine Model

Dolena R. Ledee - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved